[
  {
    "ts": "2025-08-27T10:17:06+00:00",
    "headline": "The Bull Case For Gilead Sciences (GILD) Could Change Following European Approval of Twice-Yearly HIV Prevention Injection",
    "summary": "Gilead Sciences announced that the European Commission has granted marketing authorization for Yeytuo (lenacapavir), the first and only twice-yearly injectable HIV-1 pre-exposure prophylaxis, allowing its use for adults and adolescents at increased risk in the European Union, Norway, Iceland, and Liechtenstein. This approval not only marks a regulatory milestone but also underscores lenacapavir's unique positioning as an innovative, long-acting preventive solution endorsed by both the FDA...",
    "url": "https://finance.yahoo.com/news/bull-case-gilead-sciences-gild-101706902.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ee98f15e-3ce2-35dd-b093-9a09cd9e03a5",
      "content": {
        "id": "ee98f15e-3ce2-35dd-b093-9a09cd9e03a5",
        "contentType": "STORY",
        "title": "The Bull Case For Gilead Sciences (GILD) Could Change Following European Approval of Twice-Yearly HIV Prevention Injection",
        "description": "",
        "summary": "Gilead Sciences announced that the European Commission has granted marketing authorization for Yeytuo (lenacapavir), the first and only twice-yearly injectable HIV-1 pre-exposure prophylaxis, allowing its use for adults and adolescents at increased risk in the European Union, Norway, Iceland, and Liechtenstein. This approval not only marks a regulatory milestone but also underscores lenacapavir's unique positioning as an innovative, long-acting preventive solution endorsed by both the FDA...",
        "pubDate": "2025-08-27T10:17:06Z",
        "displayTime": "2025-08-27T10:17:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HAEiJmFsYXJTRBPxnneP6w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hXB9F2qU7k4qk3_k1DQd9A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bull-case-gilead-sciences-gild-101706902.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bull-case-gilead-sciences-gild-101706902.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-27T06:56:48+00:00",
    "headline": "Analyst Says Gilead (GILD) is a ‘Very High Quality’ Cheap Stock – Here’s Why",
    "summary": "We recently published Top 10 Trending Stocks to Watch Ahead of Nvidia Earnings. Gilead Sciences Inc (NASDAQ:GILD) is one of the top trending stocks to watch ahead of Nvidia earnings. Rob Sechan from NewEdge Capital Group said in a recent program on CNBC that he’s buying Gilead Sciences Inc (NASDAQ:GILD) and explained his bullish case […]",
    "url": "https://finance.yahoo.com/news/analyst-says-gilead-gild-very-065648394.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "98dac81e-062c-3039-8dcc-702a337ea6ac",
      "content": {
        "id": "98dac81e-062c-3039-8dcc-702a337ea6ac",
        "contentType": "STORY",
        "title": "Analyst Says Gilead (GILD) is a ‘Very High Quality’ Cheap Stock – Here’s Why",
        "description": "",
        "summary": "We recently published Top 10 Trending Stocks to Watch Ahead of Nvidia Earnings. Gilead Sciences Inc (NASDAQ:GILD) is one of the top trending stocks to watch ahead of Nvidia earnings. Rob Sechan from NewEdge Capital Group said in a recent program on CNBC that he’s buying Gilead Sciences Inc (NASDAQ:GILD) and explained his bullish case […]",
        "pubDate": "2025-08-27T06:56:48Z",
        "displayTime": "2025-08-27T06:56:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/8db19b013301e9b6eb983290b544333a",
          "originalWidth": 1920,
          "originalHeight": 1280,
          "caption": "Analyst Says Gilead (GILD) is a ‘Very High Quality’ Cheap Stock - Here’s Why",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BNKqGsK3g5Qb7V0N7Yqfxw--~B/aD0xMjgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/8db19b013301e9b6eb983290b544333a.cf.webp",
              "width": 1920,
              "height": 1280,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/niXaQOBJTWQheV7_f9hqaw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/8db19b013301e9b6eb983290b544333a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/analyst-says-gilead-gild-very-065648394.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/analyst-says-gilead-gild-very-065648394.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]